Welcome to LookChem.com Sign In|Join Free

CAS

  • or

145348-16-9

Post Buying Request

145348-16-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

145348-16-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 145348-16-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,3,4 and 8 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 145348-16:
(8*1)+(7*4)+(6*5)+(5*3)+(4*4)+(3*8)+(2*1)+(1*6)=129
129 % 10 = 9
So 145348-16-9 is a valid CAS Registry Number.

145348-16-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R)-N-benzyl-1-[[4-[[(3R)-3-[benzyl(methyl)carbamoyl]piperidin-1-yl]methyl]phenyl]methyl]-N-methylpiperidine-3-carboxamide

1.2 Other means of identification

Product number -
Other names Bisbmcpx

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:145348-16-9 SDS

145348-16-9Upstream product

145348-16-9Downstream Products

145348-16-9Relevant articles and documents

Platelet aggregation inhibitory agents

-

, (2008/06/13)

The present invention relates to substantially pure stereoisomers of a compound of the formula: STR1 wherein n1 and n2 are the same or different and are 1 or 2; X is alkyl (C1 -C10), aryl (C6 -C10) or aralkyl (C7 -C12); and wherein R, R1, R2 and R3 are the same or different and are chosen from H, alkyl (C1 -C10), aryl (C6 -C10), aralkyl (C7 -C12), or a heterocyclic group, and addition salts thereof with pharmaceutically acceptable acids. The invention also relates to a method for the inhibition of blood platelet aggregation in a blood supply comprising administering to said blood supply a blood platelet aggregation inhibiting amount of the compounds of the present invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 145348-16-9